PubMed Health⌕ Search

Biomedical subjects

J L Kitzmiller

Publications and source records attributed to J L Kitzmiller.

At least 55 records · Page 3Linked to original sources

Characteristics of uterine activity during the breast stimulation stress test.

Characteristics of uterine activity produced by nipple stimulation were studied in 185 consecutive breast stimulation stress tests. Adequate contractions were produced in 95.6% of tests. Exaggerated uterine response (contractions occurring more than once every two minutes or lasting more than 90 seconds) was present in 45.5% of the patients. Twenty-one percent of the patients with such uterine activity also had a fetal heart rate (FHR) deceleration (hyperstimulation breast stimulation stress test), without adverse fetal outcome. The time in minutes from start of nipple stimulation to the first contraction (stimulation contraction interval) was recorded for each patient. Significant difference was not observed in the stimulation contraction interval distribution between the groups with and without exaggerated uterine activity. The authors conclude that there is a relatively high incidence of exaggerated uterine activity response to the breast stimulation stress test and that close surveillance of mother and fetus is warranted during antepartum nipple stimulation.

Apgar Score↗

Intravenous terbutaline and simultaneous beta 1-blockade for advanced premature labor.

Seventeen patients in advanced premature labor (cervical dilatation greater than or equal to 3 cm and effacement greater than or equal to 50%) were randomized in a double-blind protocol to receive metoprolol (a beta 1-adrenergic antagonist) or a placebo in conjunction with intravenous and oral terbutaline (a beta 2-agonist) in an attempt to inhibit the side effects of terbutaline. Both groups of patients had a dose-related increase in heart rate and systolic blood pressure and a decrease in diastolic blood pressure. Laboratory studies revealed significant hyperglycemia, hypokalemia, hypocalcemia, and acidosis during the intravenous terbutaline infusion, all of which normalized during oral terbutaline therapy. There were no significant differences in the cardiovascular or metabolic responses to terbutaline between the metroprolol and placebo patients. The mean delay in delivery was 5.7 days, with 59% of patients having delivery delayed for 48 hours or more. The mean prolongation time was shorter, but not statistically significant, for those patients receiving metroprolol. Despite the use of high-dose terbutaline, there were no significant complications of therapy. There was little efficacy of infusion dosages above 40 micrograms/min or repeated courses of intravenous tocolysis. Although recent reports do not recommend tocolysis in these patients, this study suggests that combined beta-mimetics and glucocorticoids may be the optimal care for patients in advanced premature labor, in particular, those with infants of very low birth weight.

Administration, Oral↗

Obstetrical care.

Explore the source record for details and available documents.

Congenital Abnormalities↗

Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.

Maternal serum alpha-fetoprotein (AFP) screening of routine pregnancy is a valuable tool for the prenatal detection of neural tube defects (NTDs). Against our background experience with greater than 24,000 screened pregnancies, we have studied 411 pregnant insulin-dependent diabetic women. More than a tenfold increase (19.5/1,000) in the frequency of NTDs was observed in the offspring of these diabetic patients (p less than 0.000001). Serum AFP values were lower in diabetic than in nondiabetic women. Our data indicate that the normal standard of care for diabetic pregnancy should include serum AFP screening.

Female↗

High risk antenatal hospitalization.

High risk, antenatal units have been established to provide highly sophisticated obstetric care for women with complications of pregnancy. In an effort to more precisely define the patients requiring this care, and to begin to document the benefits of antenatal hospitalization, a 2-year prospective evaluation of the Antenatal Unit (AU) at the Brigham and Women's Hospital was performed. Between July 1, 1978 and June 30, 1980, 1488 consecutive patients were admitted to the AU. Demographic data, antenatal hospitalization time, hospitalization outcome, and delivery data were determined for these patients. Diabetes mellitus, premature labor, hypertensive disorders, premature rupture of the membranes, and late pregnancy bleeding disorders resulted in over 60% of the admissions. Follow-up data demonstrated that among these 1488 patients admitted to the AU, there occurred 32 stillbirths (21.5/1000), 50 neonatal deaths (33.6/1000), and no maternal deaths. This study demonstrated that a broad spectrum of medical, surgical, and obstetric complications necessitate antenatal hospitalization, resulting in an overall perinatal survival rate of 95%.

Boston↗

Acid-base status of diabetic mothers and their infants following spinal anesthesia for cesarean section.

Acid-base status and Apgar scores were evaluated in 10 rigidly controlled insulin-dependent diabetic mothers and 10 healthy nondiabetic control women having spinal anesthesia for cesarean section. Dextrose-free intravenous solutions were used for volume expansion before induction of anesthesia, and hypotension was prevented in all cases by prompt treatment with ephedrine. There were no significant differences in the acid-base values between the diabetic and nondiabetic mothers and the infants of the diabetic and control group. Apgar scores were also similar in the two groups. If maternal diabetes is well controlled, if dextrose-containing solutions are not used for maternal intravascular volume expansion before delivery, and if maternal hypotension is avoided, spinal anesthesia can be used safely for diabetic mothers having cesarean section.

Acid-Base Equilibrium↗

Diabetic nephropathy and perinatal outcome.

We studied the effect of diabetic nephropathy on the course of pregnancy, perinatal outcome, and infant development and determined the influence of pregnancy on maternal hypertension and renal function. Maternal proteinuria usually increased during pregnancy (greater than 3 gm/24 hours in 69%), and hypertension was present by the third trimester in 73%. The degree of proteinuria correlated with diastolic pressure and creatinine clearance. After pregnancy, proteinuria declined in 65% of the mothers, hypertension was absent in 43.5%, and the expected rate of fall in creatinine clearance was not accelerated. Among 35 patients, abortion occurred spontaneously or was performed electively in 25.7%, and 71% of the remainder underwent delivery before 37 weeks. Birth weight was related to maternal blood pressure and creatinine clearance. Neonatal morbidity was common, but the perinatal survival rate was 89%. Infants seen at follow-up without congenital anomalies had normal development at 8 to 36 months of age. We concluded that perinatal outcome has significantly improved for diabetic women with nephropathy.

Adult↗

Decidual arteriopathy in hypertension and diabetes in pregnancy: immunofluorescent studies.

Lesions of the uteroplacental vasculature may be involved in the pathogenesis of "placental insufficiency" in pregnancies complicated by hypertension, diabetes, systemic lupus erythematosus, and idiopathic fetal growth retardation. The decidual arteries of the placental bed of normotensive, hypertensive, and diabetic women were studied by histologic examination and direct immunofluorescence for immunoglobulins and complement. Decidual tissue was obtained by curettage and snap frozen immediately after delivery of the placenta in 21 normal pregnant control subjects, 73 nondiabetic women with hypertensive disorders, and 41 women with insulin-dependent diabetes. Lesions of fibrinoid necrosis and/or atherosis were observed in some of the decidual arteries of 53% of women with preeclampsia (primary or superimposed) and also in a proportion of women with stable chronic hypertension or normotensive diabetes. Thus, fibrinoid necrosis/atherosis of the decidual arteries is not specific for preeclampsia. Immunoglobulins and complement were detected in arteries with lesions in subjects of all clinical groups. The findings do not support the concept that immunoprotein deposition in pathologic decidual arteries is related to a hypothetical immunologic reaction specific for preeclampsia. In preeclampsia, vascular deposition of immunoglobulin and complement may be related to local intravascular coagulation.

Arteries↗

The fetal and maternal catecholamine response to insulin-induced hypoglycemia in the rat.

This study was undertaken to evaluate the catecholamine response of the fetal rat to insulin-induced hypoglycemia in the mother. Twenty-four Sprague-Dawley rats at day 21 of gestation were used. Hypoglycemia was induced with regular insulin; then at timed intervals, the rats were anesthetized with pentobarbital. When the rats were completely unresponsive, the abdomen was opened, the fetuses were exteriorized, and fetal blood was obtained by sectioning the axillary vessels. Maternal blood was obtained from the vena cava. Plasma glucose was measured by the glucose oxidase technique. Norepinephrine, epinephrine, and dopamine were measured by radioenzymatic assay. Maternal animals demonstrated a fall in glucose to a nadir of 23 +/- 0.7 mg/dl (mean +/- SEM) and a significant rise in plasma epinephrine to a maximum of 2,548.0 +/- 1,071.2 pg/ml. Fetal glucose fell to a nadir of 23.8 +/- 3.3 mg/dl (mean +/- SEM) and fetal catecholamines demonstrated a rapid significant rise: norepinephrine rose to a maximum of 5,077.3 +/- 932.6 pg/ml; epinephrine rose to a maximum of 4,295.8 +/- 538.9 pg/ml; dopamine rose to a maximum of 869 +/- 203.3 pg/ml. The fetal correlation coefficients were r = -0.56 (p less than 0.01) for plasma glucose compared to norepinephrine and r = -0.58 (p less than 0.01) for plasma glucose compared to epinephrine. The maternal correlation coefficient for plasma glucose compared to epinephrine was r = -0.54 (p less than 0.01). These data demonstrate that the near-term fetal rat is able to respond significantly to hypoglycemia with a rapid output of catecholamines.

Animals↗

Lack of suppression of lymphocyte MIF production by estradiol, progesterone and human chorionic gonadotropin.

The hypothesis that hormones produced by the placenta contribute to immunosuppression during pregnancy is an attractive one. In order partially to evaluate this hypothesis, we utilized the Migration Inhibition Factor (MIF) Assay, which is an in vitro model of delayed hypersensitivity in that presensitized lymphocytes stimulated by antigen release a glycoprotein (MIF) which inhibits the normal migration of macrophages. The effect of placental hormones on this model of cellular immunity was tested using the direct and indirect MIF assays in pre-immunized guinea pigs. Estradiol (1-50 microgram/ml), progesterone (1-50 microgram/ml) and commercial grade or chromatography-purified hCG (1000-5000 IU/ml) did not affect normal macrophage migration and also failed to suppress production of MIF by guinea pig lymphocytes stimulated with antigen. None of the hormones either enhanced or suppressed macrophage response to preformed MIF. The results indicate that these hormones do not suppress lymphocyte reactivity as assessed by the production of lymphokines or the target cell response to the mediator. The reported effects of steroid hormones and crude hCG on other models of cellular immunity are discussed.

Animals↗

Pancreatic alpha cell response to alanine during and after normal and diabetic pregnancies.

Pancreatic alpha cell response to oral alanine was assessed in the third trimester of pregnancy and in the puerperium in 16 insulin-dependent diabetic and 7 normal pegnant women. Insulin response was also measured in the nondiabetic subjects. The nondiabetic subjects had higher basal glucagon and insulin levels as well as a greater response to oral alanine stimulation at 34 weeks' gestation than at 6 weeks post partum. In addition, basal levels of both hormones remained low at a time remote from pregnancy (9 months post partum), indicating both hyperinsulinemia and hyperglucagonemia in the postabsorptive state in normal human pregnancy. The secretory response of glucagon and insulin or oral alanine was blunted at 6 weeks post partum in the nondiabetic subjects. This suggests that the late puerperium may not be an appropriate "nonpregnant control period" for metabolic studies. During pregnancy, basal and stimulated glucagon levels were not significantly different in diabetic and normal women. Despite higher concentrations of blood glucose in diabetic women, basal and stimulated glucagon secretion was equivalent in the 2 groups. No pegnancy-induced increment in glucagon secretion was evident in insulin-treated diabetic subjects. Thus hyperglucagonemia does not contribute to the increased requirements for insulin during pregnancy in these women.

Administration, Oral↗

The infant of the diabetic mother: correlation of increased cord C-peptide levels with macrosomia and hypoglycemia.

C peptide is secreted by pancreatic beta cells in amounts equimolar with insulin, and its levels provide a direct indication of endogenous fetal levels of insulin despite the presence of maternal insulin antibodies. To determine the presence of hyperinsulinemia and its relation to the development of complications in infants of diabetic mothers, we measured cord serum levels of C peptide in 79 infants of diabetic mothers and 62 infants of nondiabetic mothers. Infants of diabetic mothers had higher cord levels of C peptide, which were significantly associated with neonatal hypoglycemia and macrosomia (P less than 0.001) but not with hyaline-membrane disease. Cord levels of C peptide in infants of diabetic mothers were elevated at the earliest gestational age studied (less than 34 weeks) and were directly related to the severity of maternal diabetes, as assessed by the White classification. We conclude that hyperinsulinemia is present in infants of diabetic mothers and that it is related to some major complications in such infants.

Birth Weight↗